BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
Company Details
- Employees
- 53
- Founded
- -
- Address
- 2836 Center Port Circle, Pompano Beach,fl 33064,united States
- Industry
- Biotechnology
- Website
- biostemtechnologies.com
- HQ
- Pompano Beach, FL
Biostem Technologies (Otc: Bsem) Questions
Biostem Technologies (Otc: Bsem)'s website is biostemtechnologies.com
Biostem Technologies (Otc: Bsem)'s LinkedIn profile is https://www.linkedin.com/company/biostem-technologies
Biostem Technologies (Otc: Bsem) has
53 employees.
View email and phone details for 53
employees at Biostem Technologies (Otc: Bsem).
Biostem Technologies (Otc: Bsem)'s industry is
Biotechnology
Biostem Technologies (Otc: Bsem)'s top competitors are
Sanuwave,
Venture Medical,
Organogenesis,
Lacerta Therapeutics,
Kerecis,
Organabio,
Mimedx,
Sanara Medtech,
Polynovo Limited,
Aroa Biosurgery Limited.
Biostem Technologies (Otc: Bsem)'s categories are Biotechnology
Biostem Technologies (Otc: Bsem)'s founding year is 2014
